FGFR Antibody
HuGAL-FR21 is a humanized monoclonal IgG1 antibody targeting FGFR2IIIb. It effectively blocks the binding of FGF2, FGF7, and FGF10 to FGFR2IIIb and inhibits FGF-induced phosphorylation of FGFR2IIIb. Additionally, HuGAL-FR21 reduces FGFR2 expression in SNU-16 cells and demonstrates significant antitumor activity in gastric cancer xenograft models in nude mice. This compound is valuable for research in cancers such as gastric cancer.
Product Specifications
Target
FGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A2296-90-01 25 mg
Anisomycin (Flagecidin, Antibiotic SA 3097C1, Antibiotic PA 106, Anhydroscopin A, NSC)
Sign In for Pricing
View Details A2296-90-02 100 mg
Anisomycin (Flagecidin, Antibiotic SA 3097C1, Antibiotic PA 106, Anhydroscopin A, NSC)
Sign In for Pricing
View Details A2296-90-03 250 mg
Anisomycin (Flagecidin, Antibiotic SA 3097C1, Antibiotic PA 106, Anhydroscopin A, NSC)
Sign In for Pricing
View Details 039541-PE 200 µL
OTUD6B, CT (OTUD6B, DUBA5, OTU domain-containing protein 6B, DUBA-5) (PE) discontinued
Sign In for Pricing
View Details K6147304 1.0 µg DNA
Mmp28 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details